Singapore markets closed
Straits Times Index
3,300.00 -4.00 (-0.12%) S&P 500
5,499.14 +12.11 (+0.22%) Dow
38,899.55 +64.69 (+0.17%) Nasdaq
17,907.10 +44.87 (+0.25%) Bitcoin USD
64,820.16 -116.70 (-0.18%) CMC Crypto 200
1,348.57 -34.09 (-2.47%)
Vera Therapeutics, Inc. (VERA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 11:07AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.94B |
| Enterprise value | 1.59B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 5.50 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.60 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.04 |
| 52-week change 3 | 125.59% |
| S&P500 52-week change 3 | 25.22% |
| 52-week high 3 | 50.78 |
| 52-week low 3 | 9.24 |
| 50-day moving average 3 | 40.33 |
| 200-day moving average 3 | 27.79 |
Share statistics
| Avg vol (3-month) 3 | 915.09k |
| Avg vol (10-day) 3 | 640.85k |
| Shares outstanding 5 | 54.7M |
| Implied shares outstanding 6 | 54.7M |
| Float 8 | 36.11M |
| % held by insiders 1 | 7.91% |
| % held by institutions 1 | 104.63% |
| Shares short (15 May 2024) 4 | 6.46M |
| Short ratio (15 May 2024) 4 | 7.07 |
| Short % of float (15 May 2024) 4 | 17.44% |
| Short % of shares outstanding (15 May 2024) 4 | 11.81% |
| Shares short (prior month 15 Apr 2024) 4 | 6.31M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -20.25% |
| Return on equity (ttm) | -36.89% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -94.3M |
| Diluted EPS (ttm) | -2.01 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 403.66M |
| Total cash per share (mrq) | 7.38 |
| Total debt (mrq) | 53.26M |
| Total debt/equity (mrq) | 15.06% |
| Current ratio (mrq) | 28.63 |
| Book value per share (mrq) | 6.49 |
Cash flow statement
| Operating cash flow (ttm) | -99.72M |
| Levered free cash flow (ttm) | -72.91M |
© 2024 Yahoo. All rights reserved.